Tirzepatide (Brand Name: Mounjaro) and Semaglutide (Brand name Rybelsus, Ozempic, Wegovy) are medications which, when used in combination with a medically supervised diet, exercise and weight management program, help with blood sugar control in type 2 diabetics, but also have been shown to cause weight loss. Tirzepatide and Semaglutide belong to class of medications called glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists, which mimic hormones in your body to lower blood sugar levels, reduce appetite, slow down the gastrointestinal tract, and make you feel fuller after you’ve eaten a meal.